Burden and cost of imported infections admitted to infectious diseases units in England and Wales in 1998 and 1999

被引:15
作者
Harling, R
Crook, P
Lewthwaite, P
Evans, M
Schmid, ML
Beeching, NJ
机构
[1] Ctr Communicable Dis Surveillance, London NW9 5HT, England
[2] N Manchester Grp Hosp, Infect Dis Unit, Manchester M8 5RB, Lancs, England
[3] Newcastle Gen Hosp, Dept Infect & Trop Med, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
[4] Royal Liverpool Univ Hosp, Trop & Infect Dis Unit, Liverpool L7 8XP, Merseyside, England
关键词
infectious disease units; imported infection; malaria;
D O I
10.1016/S0163-4453(03)00080-X
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background. International travel from the UK has been rising, and the number of imported infections has increased. This study aimed to describe the number, nature, origin, clinical burden and cost of imported infections treated in infectious disease units (IDU) in England and Wales. Method. Information about all admissions in 1998 and 1999 with illnesses considered to have been acquired during their most recent travel abroad was collected retrospectively by IDUs using a pre-piloted questionnaire. Results and analysis. Four of the 23 IDUs in England and Wales were able to complete the questionnaires. They reported a total of 421 travel related admissions during the 2-year period. Three hundred and ninety-two of these cases were attributed to infectious causes, and of these a discharge diagnosis was made for 340 cases. The total number of bed days used to treat cases of imported infection was 2918. The most common diagnosis was malaria. The odds ratio that cases of imported infection were malaria was highest following visits to Africa. The average cost per bed day on the IDUs was around El 00, and on this basis, the total cost of treating imported infections on the four IDUs in 2 years was around pound289,000. The relative risk of acquiring an imported infection requiring treatment on an IDU was greatest for travellers to Africa. Conclusions. From this study, the estimate of the total annual cost of IDU treatment for imported infections in England and Wales is in excess of pound800,000. Many cases may be preventable with prophylactic medication and vaccination and travel advice on risk reduction. Further information about imported infections would be useful to inform travel medicine services, other clinicians and travellers about the health risks associated with travel to specific areas, and help to target and assess the cost effectiveness of preventative measures. (C) 2003 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:139 / 144
页数:6
相关论文
共 17 条
[1]   IS TRAVEL PROPHYLAXIS WORTH WHILE - ECONOMIC APPRAISAL OF PROPHYLACTIC MEASURES AGAINST MALARIA, HEPATITIS-A, AND TYPHOID IN TRAVELERS [J].
BEHRENS, RH ;
ROBERTS, JA .
BRITISH MEDICAL JOURNAL, 1994, 309 (6959) :918-922
[2]  
Bradley D. J., 1992, PHLS Microbiology Digest, V9, P9
[3]  
DAY JH, 1996, BMJ-BRIT MED J, V3, P268
[4]  
DOHERTY JF, 1995, QJM-INT J MED, V88, P277
[5]  
Grobusch MP, 2003, J TRAVEL MED, V10, P164, DOI 10.2310/7060.2003.35759
[6]   Epidemiology and clinical features of imported dengue fever in Europe:: Sentinel surveillance data from TropNetEurop [J].
Jelinek, T ;
Müberger, NM ;
Harms, G ;
Corachán, M ;
Grobusch, MP ;
Knobloch, J ;
Bronner, U ;
Laferl, H ;
Kapaun, A ;
Bisoffi, Z ;
Clerinx, J ;
Puente, S ;
Fry, G ;
Schulze, M ;
Hellgren, U ;
Gjorup, I ;
Chalupa, P ;
Hatz, C ;
Matteelli, A ;
Schmid, M ;
Nielsen, LN ;
da Cunha, S ;
Atouguia, J ;
Myrvang, B ;
Fleischer, K .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (09) :1047-1052
[7]   Imported falciparum malaria in europe:: Sentinel surveillance data from the European network on surveillance of imported infectious diseases [J].
Jelinek, T ;
Schulte, C ;
Behrens, R ;
Grobusch, MP ;
Coulaud, JP ;
Bisoffi, Z ;
Matteelli, A ;
Clerinx, J ;
Corachán, M ;
Puente, S ;
Gjorup, I ;
Harms, G ;
Kollaritsch, H ;
Kotlowski, A ;
Björkmann, A ;
Delmont, JP ;
Knobloch, J ;
Nielsen, LN ;
Cuadros, J ;
Hatz, C ;
Beran, J ;
Schmid, ML ;
Schulze, M ;
Lopez-Velez, R ;
Fleischer, K ;
Kapaun, A ;
McWhinney, P ;
Kern, P ;
Atougia, J ;
Fry, G ;
da Cunha, S ;
Boecken, G .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (05) :572-576
[8]  
MACCLEAN JD, 1994, TRAVEL MED ADVISOR, V5, P1
[9]  
*MAL REF LAB, PHL5LSHTM MAL REF LI
[10]  
McKendrick M, 2003, J APPL MICROBIOL, V94, p25S